IL-17 production in barrier tissues is particularly relevant for immunosurveillance of Candida, as genetic defects in genes of the IL-17 pathway drive the development of chronic mucocutaneous candidiasis (10). Here, IL17A is linked to Chronic mucocutaneous candidosis.